2025年苯巴那酯最新价格是多少钱一盒？

Phenobarnate is a drug used to treat specific types of epilepsy. It was developed by the Italian ANGELINI company and was approved by the US FDA in 2019. In 2025, Phenomenate prices vary by strength, ranging from $117 to $521. This article will introduce in detail the latest price, global launch status and preparations before taking the drug of Phenobarate in 2025 to help patients and their families better understand this drug.

What is the latest price of a box of Phenobarate in 2025?

The price varies depending on specifications and manufacturers. In 2025, the price of phenoparate produced by Italian ANGELINI company is as follows.

Price comparison of different specifications

The price of 12.5mg+25mg*28 tablets is about US$206/box; the price of 50mg*84 tablets and 200mg*84 tablets is about US$521/box; the price of 50mg*28 tablets is about US$231/box; the price of 50mg*14 tablets is about US$117/box.

Price Influencing Factors

The price of Phenobarnate is affected by specifications, packaging quantity and market demand. Large-format packaging usually has a lower unit price, while small-format packaging is more suitable for short-term medication needs.

Patients can choose appropriate specifications according to their own medication needs. At the same time, they must pay attention to the authenticity and source reliability of the medicine.

Global marketing status of Phenobarnate

Phenobarnate has been approved for marketing in some countries and regions, but has not yet been approved in China.

U.S. market

In November 2019, Phenobarnate was approved by the U.S. FDA for the treatment of specific types of epilepsy. Currently, the supply in the U.S. market is stable and patients can purchase it through formal channels.

European Market

Many European countries have also approved the marketing of Phenobarnate, especially Italian ANGELINI Company, as the main manufacturer, with a wide supply coverage.

Chinese market

Phenobarnate has not yet been launched in China, nor has it been included in the medical insurance catalog. If domestic patients need to purchase it, they need to obtain it through cross-border medical service institutions or cross-border e-commerce platforms.

Globally, the marketing status of phenobarnate varies greatly, and patients need to choose purchase channels based on the actual situation in their region.

Preparation for the use of Phenobarate

Before using Phenomenate, the patient must be fully prepared for the medication.

Pre-medication examination

Patients should undergo a comprehensive physical examination, especially liver function and electrocardiogram tests, to evaluate whether they are suitable for the use of phenoparate.

Dose adjustment

For patients with mild to moderate liver function impairment, the maximum recommended dose is 200 mg/day; use is not recommended for patients with severe liver function impairment. The specific dosage needs to be determined by the doctor based on the patient's condition.

Dosage

Phenobarnate can be taken as a whole tablet or crushed and mixed with water to form a suspension for oral administration. When administering via nasogastric tube, steps must be followed to ensure that the drug is fully taken.

Adverse reactions need to be monitored regularly during medication. If serious discomfort occurs, you should seek medical treatment in time to adjust the treatment plan.